Totally-drug-resistant tuberculosis: hype versus hope

Affiliations

¹ Therapeutic Immunology Division, Department of Laboratory Medicine, Karolinska Institutet, Hälsövägen F79, Huddinge, SE-14186 Stockholm, Sweden; Center for Allogeneic Stem Cell Transplantation, Karolinska University Hospital, Stockholm, Sweden. Electronic address: markus.maeurer@ki.se.
² Henry M Jackson Foundation-Division of AIDS, Tuberculosis Clinical Research Branch, National Institute of Allergy and infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
³ Division of Infection and Immunity, University College London, London, UK; Department of Medical Microbiology, University College London Hospitals NHS Trust, London, UK.

Markus Maeurer et al. Lancet Respir Med. 2014 Apr.

. 2014 Apr;2(4):256-7.

doi: 10.1016/S2213-2600(14)70020-7. Epub 2014 Mar 24.

¹ Therapeutic Immunology Division, Department of Laboratory Medicine, Karolinska Institutet, Hälsövägen F79, Huddinge, SE-14186 Stockholm, Sweden; Center for Allogeneic Stem Cell Transplantation, Karolinska University Hospital, Stockholm, Sweden. Electronic address: markus.maeurer@ki.se.
² Henry M Jackson Foundation-Division of AIDS, Tuberculosis Clinical Research Branch, National Institute of Allergy and infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
³ Division of Infection and Immunity, University College London, London, UK; Department of Medical Microbiology, University College London Hospitals NHS Trust, London, UK.

No abstract available

MeSH terms